IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 104 filers reported holding IVERIC BIO INC in Q3 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $17,884,711 | +99.7% | 454,619 | +23.5% | 0.01% | +50.0% |
| Q1 2023 | $8,955,776 | +988.1% | 368,096 | +857.5% | 0.00% | – |
| Q4 2022 | $823,044 | +34.0% | 38,442 | +12.3% | 0.00% | – |
| Q3 2022 | $614,000 | -53.9% | 34,246 | -75.3% | 0.00% | -100.0% |
| Q2 2022 | $1,333,000 | -69.1% | 138,575 | -46.0% | 0.00% | 0.0% |
| Q1 2022 | $4,319,000 | +95.5% | 256,600 | +94.2% | 0.00% | 0.0% |
| Q4 2021 | $2,209,000 | -71.5% | 132,101 | -72.4% | 0.00% | -66.7% |
| Q3 2021 | $7,760,000 | +3395.5% | 477,815 | +1255.5% | 0.00% | – |
| Q2 2021 | $222,000 | +93.0% | 35,250 | +89.6% | 0.00% | – |
| Q1 2021 | $115,000 | -89.0% | 18,594 | -87.7% | 0.00% | -100.0% |
| Q4 2020 | $1,046,000 | +566.2% | 151,388 | +392.2% | 0.00% | – |
| Q2 2020 | $157,000 | -21.5% | 30,755 | -47.1% | 0.00% | – |
| Q1 2020 | $200,000 | – | 58,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,583,786 | $8,888,000 | 9.40% |
| Soleus Capital Management, L.P. | 1,607,153 | $5,529,000 | 6.43% |
| Burrage Capital Management LLC | 1,521,382 | $4,990,000 | 4.91% |
| VR Adviser, LLC | 2,586,537 | $8,898,000 | 2.41% |
| Samsara BioCapital, LLC | 862,552 | $2,967,000 | 1.71% |
| Tamarack Advisers, LP | 1,250,000 | $4,300,000 | 1.63% |
| Consonance Capital Management LP | 3,150,565 | $10,838,000 | 0.81% |
| Ghost Tree Capital, LLC | 828,459 | $2,850,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,267,409 | $7,800,000 | 0.25% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $478,000 | 0.23% |